biomee ApS: Financial statements 2025
CVR: 29829586
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
biomee ApS (CVR 29829586) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 4,813,840 and a net result of DKK 6,548,744 compared with DKK 5,547,134 the year before. That is an increase of 8.3% compared with the year before. Equity in the 2025 report amounted to DKK 23,772,837. The solvency ratio was 93.2%.
- Gross Profit
- DKK 4,813,840
- Profit/Loss
- DKK 6,548,744
- Equity
- DKK 23,772,837
- Total Assets
- DKK 25,507,993
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 4.8 mio. | 6.5 mio. | 23.8 mio. | 0 |
| 2024 | - | 4.4 mio. | 5.5 mio. | 17.2 mio. | - |
| 2023 | - | 7.5 mio. | 7.9 mio. | 11.7 mio. | - |
| 2022 | - | 3.6 mio. | 3.6 mio. | 3.8 mio. | - |
| 2021 | - | 8.6 mio. | 7.8 mio. | 208 t. | - |
Official annual report
How creditworthy is biomee ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
Biomee ApS has published its annual report for 2024. Gross profit came to DKK 4,444,339, and the net result was DKK 5,547,134.
As of May 27, 2025, Trine Ahlgreen is registered as director of biomee ApS.
As of May 27, 2025, Jesper Jørn Lange has stepped down as director of biomee ApS.
About biomee ApS
biomee ApS is a Danish company of the type Anpartsselskab based in Hørsholm, founded in 2006. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named DRUG DELIVERY SOLUTIONS ApS and TOXICELL ApS. The management consists of Trine Ahlgreen. The company is owned by MC2 Therapeutics A/S. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 4,813,840 and a net result of DKK 6,548,744 compared with DKK 5,547,134 the year before. Equity in the 2025 report amounted to DKK 23,772,837.